Loading...
Cerus
CERS · NASDAQ🇺🇸
Loading...
Key Statistics
Market Cap
$448M
P/E Ratio
-21.07
Sector
N/A
Industry
N/A
52-Week High
$2.72
52-Week Low
$1.13
Product Gross Margin
55.2%
Non-GAAP Adjusted EBITDA
$935K
Operating Cash Flows
-$2.4M
Platelet Kit Growth Worldwide
3%
Treatable Platelet Doses Growth Worldwide
1%
Cerus Revenue by Segment
Cerus Revenue by Geographic Location
Revenue by Segment
Revenue by Geographic Location
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...